MRK
XNYSMERCK & CO. INC.
3 news · 90d
0 news · vs previous 7d (—)
Acceleration +0.000 (vs prior 7d)
Daily digest
Track $MRK sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 3
How did the price react? →- Merck Animal Health to buy biodevice developer TARGAN
Merck Animal Health, a division of Merck & Co., has announced an agreement to acquire TARGAN, a developer of biodevices for animal health applications. Financial terms of the deal were not disclosed in the headline. The acquisition expands Merck Animal Health's technology portfolio in the biodevice space.
- Apr 24 15:06▲ 0.50Yahoorel 20%Alphabet Cloud AI Push And Valuation Outlook After Gemini And TPU News
Alphabet's Google Cloud unveiled TPU 8t and 8i AI chips, the Gemini Enterprise Agent Platform, and a $750M enterprise AI adoption fund at its Cloud Next conference. The announcements include partnerships with Nvidia, Broadcom, Marvell, Merck, Salesforce, Deloitte, and Ulta Beauty. GOOGL was trading around $338.89 at the time of the article.
- Merck acquisition of Terns passes HSR waiting period expiration
Merck's proposed acquisition of Terns Pharmaceuticals has cleared a key regulatory hurdle, with the Hart-Scott-Rodino (HSR) antitrust waiting period expiring without a challenge. This indicates U.S. antitrust regulators have no objection to the deal, moving it closer to completion. No revised deal terms or timeline for closing were mentioned in the article.